Maquetación 1
Trabajo para frenar la predisposición genética al cáncer" | Últimas noticias de la actualidad cultural en Diario de Navarra
Breakthrough for Dundee cancer research
p53 Turns Thirty - Life Sciences | Weizmann Wonder Wander - News, Features and Discoveries
nº 69 noticias.cun by Clínica Universidad de Navarra - Issuu
David Lane Group | Karolinska Institutet
ecancer
Maquetación 1
areap53 – Page 2
A*STAR's Chief Scientist On COVID-19 Immunity And Antibody Drugs (VIDEO) - Asian Scientist Magazine
p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research
The Dr. Josef Steiner Cancer Research Foundation
A chat with Sir David Lane on COVID-19 immunity and antibody drugs - YouTube
Professor Sir David Lane with the Cancer Research UK Lifetime... | Download Scientific Diagram
A Chat With A*STAR Chief Scientist, Professor Sir David Lane - Part I - Asian Scientist Magazine
Singapore confers Honorary Citizen Award on Professor Sir David Philip Lane
Man of Science: Celebrating Professor Sir David Lane's 60th anniversary
Cancers | Free Full-Text | The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure
Stream Spiro Rombotis, President/CEO, Cyclacel (Cyclacel.com). Their founding scientist Professor Sir David Lane discovered p53, a key tumor suppressor gene that malfunctions in about 2/3 of human cancers; and he oversees drug
p53 and cancer research: an interview with Professor Sir David Lane, Scientific Director of the Ludwig Institute for Cancer Research
Professor Sir David Lane, A-STAR, Singapore // “40 years of p53. From discovery to the clinic” - EPFL
p53 – the guardian of the genome | Karolinska Institutet
Maquetación 1
Prof. Sir DAVID LANE: Targeting p53 in cancer therapy: reality or fantasy, Sofia, 2017 - YouTube
The Challenges: Professor Sir David Lane shares his thoughts on the macromolecules challenge | Cancer Grand Challenges
